CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade

SIMPLE SUMMARY: The recent discovery of immune checkpoint inhibitors constituted a breakthrough in cancer treatment, but most patients are resistant to this therapy. Although the co-stimulatory molecule cluster of differentiation (CD) 80 has been detected in several types of tumor cells, its role in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vackova, Julie, Polakova, Ingrid, Johari, Shweta Dilip, Smahel, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072777/
https://www.ncbi.nlm.nih.gov/pubmed/33923750
http://dx.doi.org/10.3390/cancers13081935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072777/
https://www.ncbi.nlm.nih.gov/pubmed/33923750
http://dx.doi.org/10.3390/cancers13081935

Ejemplares similares